Cybersecurity Incident Impacting Compumedics Limited

Compumedics Limited (ASX: CMP) (“Compumedics” or “Company”) has confirmed that it has been the victim of a cyber security incident caused by a ransomware attack after unusual activity was recently detected in its IT network. The incident has impacted the data on some of our systems in Australia and the United States of America.

Steps have been taken to contain and remediate the incident and to secure the network. The impacted data is backed up daily. While our business operations remain unaffected, all servers were taken offline as a precaution. Our Australian servers are now being restored as they are checked. However, some of our Nexus360 customers are still offline. Nexus360 is our web-based patient data and Lab Management System that provides integrated hardware and software solutions for both Sleep and Neurology clinics.

An independent forensic investigation into the incident is ongoing to understand what happened, its impact on our customers’ data including their patient reports, and to ensure our systems are secure, so normal services can be resumed as soon as possible.

A report has been made to the Australian Cyber Security Centre (part of the Australian Signals Directorate). We will be determining what further notifications are required as the investigation continues.

About Compumedics Limited

Compumedics Limited [ASX: CMP] is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The Company owns US based Neuroscan and Germany based DWL Elektronishe GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including the Americas, Australia and Asia Pacific, Europe and the Middle East.

Executive Chairman Dr. David Burton founded Compumedics in 1987. In the same year the Company successfully designed and installed the first Australian, fully computerised sleep clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets.

Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards, including Australia’s Exporter of the Year, and has been recognised as a Top 100 Innovator by both German and Australian governments.

For further information please contact:

Dr David Burton
Executive Chairman, CEO Executive Director
Compumedics Limited
Phone: + 61 3 8420 7300
Fax: +61 3 8420 7399

David Lawson
Chief Financial Officer
Compumedics Limited
Phone: + 61 3 8420 7300
Fax: +61 3 8420 7399

Authorised for lodgement by Compumedics Limited’s Board of Directors